|
DNAJC24 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.38777878078145E-14 |
| Normal-vs-Stage2 |
3.83350018395845E-10 |
| Normal-vs-Stage3 |
3.90589782739426E-11 |
| Normal-vs-Stage4 |
4.48530101948563E-14 |
| Stage1-vs-Stage2 |
3.774600E-01 |
| Stage1-vs-Stage3 |
2.138600E-01 |
| Stage1-vs-Stage4 |
1.043580E-02 |
| Stage2-vs-Stage3 |
8.585200E-01 |
| Stage2-vs-Stage4 |
1.606800E-01 |
| Stage3-vs-Stage4 |
1.984040E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.93839999998546E-07 |
| Normal-vs-Asian |
1.99679999979274E-07 |
| Caucasian-vs-AfricanAmerican |
9.433400E-01 |
| Caucasian-vs-Asian |
1.037780E-01 |
| AfricanAmerican-vs-Asian |
3.215600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.88258347483861E-14 |
| Normal-vs-Female |
1.62525548574877E-12 |
| Male-vs-Female |
3.726200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.97164506943182E-12 |
| Normal-vs-Age(41-60Yrs) |
8.07132138902489E-14 |
| Normal-vs-Age(61-80Yrs) |
2.13284945260739E-12 |
| Normal-vs-Age(81-100Yrs) |
2.659200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.282600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.794830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.989800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.359400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.782800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.411400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.429000E-01 |
| Classical-VS-Follicular |
3.969600E-01 |
| Classical-VS-Other |
5.292800E-01 |
| Classical-VS-Normal |
1.62558855265615E-12 |
| Tall-VS-Follicular |
1.639960E-01 |
| Tall-VS-Other |
9.881400E-01 |
| Tall-VS-Normal |
7.31549999466452E-08 |
| Follicular-VS-Other |
4.317600E-01 |
| Follicular-VS-Normal |
4.30330000522616E-08 |
| Other-VS-Normal |
1.415240E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.13242748511766E-14 |
| Normal-vs-N1 |
1.4580999740943E-09 |
| N0-vs-N1 |
6.978000E-01 |
|
|
